Award information
2025 Winner
Picture shows, left to right;
Nina Hossain, awards presenter; Thomas Stockman, European Head, Healthcare Investment Banking, RBC Capital Markets (award sponsor); Joseph Sanderson, VP Research, Adaptimmune Therapeutics plc (award winner); Melody A. Carey, President & Chief Executive Officer, Rx Communications Group, LLC (Mainline sponsor); and Neil Shah, Executive Director, Content & Strategy, Edison Group (Mainline sponsor).
2025 Shortlist
- Adaptimmune Therapeutics plc
- Allergy Therapeutics plc
- ANGLE plc
- Avacta Group plc
- Creo Medical Group plc
- Scancell Holdings plc
Criteria
The technology that lies at the heart of this award does not have to be proven, but it will, in the eyes of the Voting Panel, be innovative, well funded, and capable of significant commercial success. The technology concerned could have been developed within the organisation or acquired.